Hepatitis B vaccination failure in children with Diabetes Mellitus? The debate continues

References

• World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec 2009; 84:405 - 19; PMID: 19817017
   PubMedGoogle Scholar
• Coates T, Wilson R, Patrick G, André F, Watson V. Hepatitis B vaccines: assessment of the seroprotective efficacy of two recombinant DNA vaccines. Clin Ther 2001; 23:392 - 403; http://dx.doi.org/10.1016/S0149-2918(01)80044-8; PMID: 11318074
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romanò L, D’Amelio R, Chironna M, Coppola RC, et al, Study Group. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet 2005; 366:1379 - 84; http://dx.doi.org/10.1016/S0140-6736(05)67568-X; PMID: 16226616
   PubMed Web of Science ®Google Scholar
• Kubba AK, Taylor P, Graneek B, Strobel S. Non-responders to hepatitis B vaccination: a review. Commun Dis Public Health 2003; 6:106 - 12; PMID: 12889288
   PubMedGoogle Scholar
• Wood RC, MacDonald KL, White KE, Hedberg CW, Hanson M, Osterholm MT. Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workers. JAMA 1993; 270:2935 - 9; http://dx.doi.org/10.1001/jama.1993.03510240047030; PMID: 8254853
   PubMed Web of Science ®Google Scholar
• Alper CA, Kruskall MS, Marcus-Bagley D, Craven DE, Katz AJ, Brink SJ, et al. Genetic prediction of nonresponse to hepatitis B vaccine. N Engl J Med 1989; 321:708 - 12; http://dx.doi.org/10.1056/NEJM198909143211103; PMID: 2528067
   PubMed Web of Science ®Google Scholar
• Leonardi S, Spina M, Spicuzza L, Rotolo N, La Rosa M. Hepatitis B vaccination failure in celiac disease: is there a need to reassess current immunization strategies?. Vaccine 2009; 27:6030 - 3; http://dx.doi.org/10.1016/j.vaccine.2009.07.099; PMID: 19682619
   PubMed Web of Science ®Google Scholar
• Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS Immunol Med Microbiol 1999; 26:259 - 65; http://dx.doi.org/10.1111/j.1574-695X.1999.tb01397.x; PMID: 10575137
   PubMed Web of Science ®Google Scholar
• Martinetti M, De Silvestri A, Belloni C, Pasi A, Tinelli C, Pistorio A, et al. Humoral response to recombinant hepatitis B virus vaccine at birth: role of HLA and beyond. Clin Immunol 2000; 97:234 - 40; http://dx.doi.org/10.1006/clim.2000.4933; PMID: 11112362
   PubMed Web of Science ®Google Scholar
• Wang C, Tang J, Song W, Lobashevsky E, Wilson CM, Kaslow RA. HLA and cytokine gene polymorphisms are independently associated with responses to hepatitis B vaccination. Hepatology 2004; 39:978 - 88; http://dx.doi.org/10.1002/hep.20142; PMID: 15057902
   PubMed Web of Science ®Google Scholar
• Godkin A, Davenport M, Hill AVS. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 2005; 41:1383 - 90; http://dx.doi.org/10.1002/hep.20716; PMID: 15915462
   PubMed Web of Science ®Google Scholar
• Stachowski J, Kramer J, Füst G, Maciejewski J, Baldamus CA, Petrányi GG. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol 1995; 42:60 - 5; http://dx.doi.org/10.1111/j.1365-3083.1995.tb03626.x; PMID: 7631146
   PubMed Web of Science ®Google Scholar
• Noble JA, Valdes AM, Thomson G, Erlich HA. The HLA class II locus DPB1 can influence susceptibility to type 1 diabetes. Diabetes 2000; 49:121 - 5; http://dx.doi.org/10.2337/diabetes.49.1.121; PMID: 10615959
   PubMed Web of Science ®Google Scholar
• Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G, EURODIAB Study Group. Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study. Lancet 2009; 373:2027 - 33; http://dx.doi.org/10.1016/S0140-6736(09)60568-7; PMID: 19481249
   PubMed Web of Science ®Google Scholar
• Pozzilli P, Arduini P, Visalli N, Sutherland J, Pezzella M, Galli C, et al. Reduced protection against hepatitis B virus following vaccination in patients with type 1 (insulin-dependent) diabetes. Diabetologia 1987; 30:817 - 9; http://dx.doi.org/10.1007/BF00275749; PMID: 2962892
   PubMed Web of Science ®Google Scholar
• Bouter KP, Diepersloot RJA, Wismans PJ, Gmelig Meyling FH, Hoekstra JB, Heijtink RA, et al. Humoral immune response to a yeast-derived hepatitis B vaccine in patients with type I diabetes mellitus. Diabet Med 1992; 9:66 - 9; http://dx.doi.org/10.1111/j.1464-5491.1992.tb01717.x; PMID: 1532355
   PubMed Web of Science ®Google Scholar
• Fiçicioğlu C, Mikla S, Midilli K, Aydin A, Cam H, Erğin S. Reduced immune response to hepatitis B vaccine in children with insulin dependent diabetes. Acta Paediatr Jpn 1995; 37:687 - 90; PMID: 8775551
   PubMedGoogle Scholar
• Fabrizi F, Dixit V, Martin P, Messa P. Meta-analysis: the impact of diabetes mellitus on the immunological response to hepatitis B virus vaccine in dialysis patients. Aliment Pharmacol Ther 2011; 33:815 - 21; http://dx.doi.org/10.1111/j.1365-2036.2011.04589.x; PMID: 21281319
   PubMed Web of Science ®Google Scholar
• Alavian SM, Tabatabaei SV. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: A meta-analysis of current literature. Vaccine 2010; 28:3773 - 7; http://dx.doi.org/10.1016/j.vaccine.2010.03.038; PMID: 20371390
   PubMed Web of Science ®Google Scholar
• Stachowski J, Kramer J, Füst G, Maciejewski J, Baldamus CA, Petrányi GG. Relationship between the reactivity to hepatitis B virus vaccination and the frequency of MHC class I, II and III alleles in haemodialysis patients. Scand J Immunol 1995; 42:60 - 5; http://dx.doi.org/10.1111/j.1365-3083.1995.tb03626.x; PMID: 7631146
   PubMed Web of Science ®Google Scholar
• Ada G. Vaccines and vaccination. N Engl J Med 2001; 345:1042 - 53; http://dx.doi.org/10.1056/NEJMra011223; PMID: 11586958
   PubMed Web of Science ®Google Scholar
• Douvin C, Simon D, Charles MA, Deforges L, Bierling P, Lehner V, et al. Hepatitis B vaccination in diabetic patients. Randomized trial comparing recombinant vaccines containing and not containing pre-S2 antigen. Diabetes Care 1997; 20:148 - 51; http://dx.doi.org/10.2337/diacare.20.2.148; PMID: 9118762
   PubMed Web of Science ®Google Scholar
• Marseglia GL, Scaramuzza A, d’Annunzio G, Comolli G, Gatti M, Lorini R. Successful immune response to a recombinant hepatitis B vaccine in young patients with insulin-dependent diabetes mellitus. Diabet Med 1996; 13:630 - 3; http://dx.doi.org/10.1002/(SICI)1096-9136(199607)13:7<630::AID-DIA137>3.0.CO;2-7; PMID: 8840096
   PubMed Web of Science ®Google Scholar
• Marseglia GL, Alibrandi A, d’Annunzio G, Gulminetti R, Avanzini MA, Marconi M, et al. Long term persistence of anti-HBs protective levels in young patients with type 1 diabetes after recombinant hepatitis B vaccine. Vaccine 2000; 19:680 - 3; http://dx.doi.org/10.1016/S0264-410X(00)00268-1; PMID: 11115688
   PubMed Web of Science ®Google Scholar
• Halota W, Muszyńska M, Pawłowska M. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes. Med Sci Monit 2002; 8:CR516 - 9; PMID: 12118201
   PubMedGoogle Scholar
• Cetin B, Arslanoglu I, Ilgezdi N, et al. Anti-HBs antibody levels in type-1 diabetic children after hepatitis B vaccination. First World Congress on vaccines and Immunization, Istambul, Turkey 1998; 26-30.
   Google Scholar
• Arslanoğlu I, Cetin B, Işgüven P, Karavuş M. Anti-HBs response to standard hepatitis B vaccination in children and adolescents with diabetes mellitus. J Pediatr Endocrinol Metab 2002; 15:389 - 95; http://dx.doi.org/10.1515/JPEM.2002.15.4.389; PMID: 12008685
   PubMed Web of Science ®Google Scholar
• Li Volti S, Caruso-Nicoletti M, Biazzo F, Sciacca A, Mandarà G, Mancuso M, et al. Hyporesponsiveness to intradermal administration of hepatitis B vaccine in insulin dependent diabetes mellitus. Arch Dis Child 1998; 78:54 - 7; http://dx.doi.org/10.1136/adc.78.1.54; PMID: 9534677
   PubMed Web of Science ®Google Scholar
• Zuckerman JN, Sabin C, Craig FM, Williams A, Zuckerman AJ. Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ 1997; 314:329 - 33; http://dx.doi.org/10.1136/bmj.314.7077.329; PMID: 9040320
   PubMed Web of Science ®Google Scholar
• Leonardi S, Del Giudice MM, Spicuzza L, Spina M, La Rosa M. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study. Am J Gastroenterol 2010; 105:2117 - 9; http://dx.doi.org/10.1038/ajg.2010.195; PMID: 20818367
   PubMed Web of Science ®Google Scholar
• Franzese A, Iafusco D, Spadaro R, Cavaliere O, Prisco F, Auricchio R, et al, Study-Group on Diabetes of Italian Society of Pediatric Endocrinology and Diabetology. Potential celiac disease in type 1 diabetes: a multicenter study. Diabetes Res Clin Pract 2011; 92:53 - 6; http://dx.doi.org/10.1016/j.diabres.2010.12.028; PMID: 21239079
   PubMed Web of Science ®Google Scholar